Rua Life Sciences PLC
LSE:RUA
Rua Life Sciences PLC
Revenue
Rua Life Sciences PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rua Life Sciences PLC
LSE:RUA
|
Revenue
£2.2m
|
CAGR 3-Years
64%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Abingdon Health PLC
LSE:ABDX
|
Revenue
£4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
ConvaTec Group PLC
LSE:CTEC
|
Revenue
$2.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Tristel PLC
LSE:TSTL
|
Revenue
£39.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
Inspecs Group PLC
LSE:SPEC
|
Revenue
£203.3m
|
CAGR 3-Years
62%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Revenue
£126.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
See Also
What is Rua Life Sciences PLC's Revenue?
Revenue
2.2m
GBP
Based on the financial report for Mar 31, 2023, Rua Life Sciences PLC's Revenue amounts to 2.2m GBP.
What is Rua Life Sciences PLC's Revenue growth rate?
Revenue CAGR 5Y
40%
Over the last year, the Revenue growth was 34%. The average annual Revenue growth rates for Rua Life Sciences PLC have been 64% over the past three years , 40% over the past five years .